Acta Pharmaceutica, Vol. 64 No. 2, 2014.
Original scientific paper
https://doi.org/10.2478/acph-2014-0012
Complexation of Z-ligustilide with hydroxypropyl-β-cyclodextrin to improve stability and oral bioavailability
YAPENG LU
; Institute of Nautical Medicine, Nantong University, Nantong 226001, China
SIYUAN LIU
; School of Life Sciences, Nantong University, Nantong 226007, China
YU ZHAO
; Institute of Nautical Medicine, Nantong University, Nantong 226001, China
LI ZHU
; Institute of Nautical Medicine, Nantong University, Nantong 226001, China
SHUQIN YU
orcid.org/0000-0002-2824-4651
; Jiangsu Key Laboratory for Supramolecular Medicinal Materials and Applications, College of Life Science, Nanjing Normal University, Nanjing 210046, China
Abstract
To improve the stability and oral bioavailability of Z-ligustilide (LIG), the inclusion complex of LIG with hydroxypropyl-β-cyclodextrin (HP-β-CD) was prepared by the kneading method and characterized by UV-Vis spectroscopy, differential thermal analysis (DTA) and Fourier transform infrared (FTIR) spectroscopy. LIG is capable of forming an inclusion complex with HP-β-CD and the stoichiometry of the complex was 1:1. Stability of the inclusion complex against temperature and light was greatly enhanced compared to that of free LIG. Further, oral bioavailability of LIG and the inclusion complex in rats were studied and the plasma drug concentration-time curves fitted well with the non-compartment model to estimate the absolute bioavailability, which was 7.5 and 35.9 %, respectively. In conclusion, these results show that LIG/HP-β-CD complexation can be of great use for increasing the stability and biological efficacy of LIG.
Keywords
Z-ligustilide; hydroxypropyl-β-cyclodextrin; inclusion complex; stability; bioavailability
Hrčak ID:
114596
URI
Publication date:
30.6.2014.
Visits: 2.105 *